mardi 4 avril 2017
EpiPen maker Mylan faces proposed class action lawsuit in U.S.
Pharmaceutical firm Mylan NV has been hit with a new proposed class action lawsuit in the U.S. over the price of its EpiPen allergy treatment, which shot up to more than $600 US for a two-pack of the device from less than $100 in 2007.
Related Posts:
Articles
0 comments:
Enregistrer un commentaire